About this Journal Submit a Manuscript Table of Contents
Chemotherapy Research and Practice
Volume 2011 (2011), Article ID 806256, 12 pages
http://dx.doi.org/10.1155/2011/806256
Review Article

Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia

Brigham and Women's Hospital and Dana-Farber Cancer Institute, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New England Trophoblastic Disease Center, Harvard Medical School, Boston, MA 02115, USA

Received 20 January 2011; Accepted 1 March 2011

Academic Editor: Kazuo Tamura

Copyright © 2011 Taymaa May et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Palmer, “Advances in the epidemiology of gestational trophoblastic disease,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 39, no. 3, pp. 155–162, 1994. View at Scopus
  2. J. T. Soper and C. B. Hammond, “Gestational trophoblastic neoplasms,” in Danforth’s Obstetrics and Gynecology, J. R. Scott, P. J. DiSaia, C. B. Hammond, and W. D. Spellacy, Eds., pp. 1141–1155, J. B. Lipincott, Philadelphia, Pa, USA, 6th edition, 1990.
  3. K. D. Bagshawe, “Risk and prognostic factors in trophoblastic neoplasia,” Cancer, vol. 38, no. 3, pp. 1373–1385, 1976. View at Scopus
  4. D. P. Goldstein and R. S. Berkowitz, “Gestational trophoblastic neoplasms: clinical principles of diagnosis and management,” in Major Problems in Obstetrics and Gynecology, W. B. Saunders, Philadelphia, Pa, USA, 1982.
  5. J. R. Lurain, “Advances in management of high-risk gestational trophoblastic tumors,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 47, no. 6, pp. 451–459, 2002. View at Scopus
  6. B. H. Martin and J. H. Kim, “Changes in gestational trophoblastic tumors over four decades: a Korean experience,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 43, no. 1, pp. 60–68, 1998. View at Scopus
  7. C. B. Hammond, J. C. Weed, and J. L. Currie, “The role of operation in the current therapy of gestational trophoblastic disease,” American Journal of Obstetrics and Gynecology, vol. 136, no. 7, pp. 844–858, 1980. View at Scopus
  8. J. R. Lurain, D. K. Singh, and J. C. Schink, “Role of surgery in the management of high-risk gestational trophoblastic neoplasia,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 10, pp. 773–776, 2006. View at Scopus
  9. D. G. Mutch, J. T. Soper, and M. E. Baker, “Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease,” Obstetrics and Gynecology, vol. 68, no. 3, pp. 348–352, 1986. View at Scopus
  10. E. I. O. Garner, A. Garrett, D. P. Goldstein, and R. S. Berkowitz, “Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 6, pp. 411–414, 2004. View at Scopus
  11. K. D. Bagshawe and S. Harland, “Immunodiagnosis and monitoring of gonadotrophin producing metastases in the central nervous system,” Cancer, vol. 38, no. 1, pp. 112–118, 1976. View at Scopus
  12. Y. Bakri, N. Al-Hawashim, and R. Berkowitz, “CSF/serum β-hCG ratio in patients with brain metastases of gestational trophoblastic tumor,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 45, no. 2, pp. 94–96, 2000. View at Scopus
  13. T. Dhillon, C. Palmieri, N. J. Sebire et al., “Value of whole body FDG-PET to identify the active site of gestational trophoblastic neoplasia,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 11, pp. 879–887, 2006. View at Scopus
  14. R. S. Berkowitz and D. P. Goldstein, “Chorionic tumors,” New England Journal of Medicine, vol. 335, no. 23, pp. 1740–1798, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. E. I. Kohorn, “Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia: a progress report,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 47, no. 6, pp. 445–450, 2002. View at Scopus
  16. R. S. Berkowitz and D. P. Goldstein, “Pathogenesis of gestational trophoblastic neoplasms,” Pathobiology Annual, vol. 11, pp. 391–411, 1981. View at Scopus
  17. R. S. Berkowitz and D. P. Goldstein, “Current management of gestational trophoblastic diseases,” Gynecologic Oncology, vol. 112, no. 3, pp. 654–662, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. W. B. Jones, K. M. Wagner-Reiss, and J. L. Lewis, “Intracerebral choriocarcinoma,” Gynecologic Oncology, vol. 38, no. 2, pp. 234–243, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Bakri, R. S. Berkowitz, D. P. Goldstein et al., “Brain metastases of gestational trophoblastic tumor,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 39, no. 3, pp. 179–184, 1994. View at Scopus
  20. M. S. Cagayan and L. R. Lu-Lasala, “Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 10, pp. 785–792, 2006. View at Scopus
  21. A. Athanassiou, R. H. J. Begent, and E. S. Newlands, “Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital,” Cancer, vol. 52, no. 9, pp. 1728–1735, 1983. View at Scopus
  22. T. L. Liu, G. Deppe, Q. T. Chang, and T. T. Tan, “Cerebral metastatic choriocarcinoma in the People's Republic of China,” Gynecologic Oncology, vol. 15, no. 2, pp. 166–170, 1983. View at Scopus
  23. Y. N. Bakri, J. Subhi, M. Amer et al., “Liver metastases of gestational trophoblastic tumor,” Gynecologic Oncology, vol. 48, no. 1, pp. 110–113, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. R. S. Berkowitz, D. P. Goldstein, and M. R. Bernstein, “Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease,” Gynecologic Oncology, vol. 23, no. 1, pp. 111–118, 1986. View at Scopus
  25. H. D. Homesley, “Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 43, no. 1, pp. 69–74, 1998. View at Scopus
  26. R. Osathanondh, D. P. Goldstein, and G. B. Pastorfide, “Actinomycin D as the primary agent for gestational trophoblastic disease,” Cancer, vol. 36, no. 3, pp. 863–866, 1975. View at Scopus
  27. K. D. Bagshawe, J. Dent, E. S. Newlands, R. H. J. Begent, and G. J. S. Rustin, “The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT),” British Journal of Obstetrics and Gynaecology, vol. 96, no. 7, pp. 795–802, 1989. View at Scopus
  28. J. R. Lurain, “Treatment of gestational trophoblastic tumors,” Current Treatment Options in Oncology, vol. 3, no. 2, pp. 113–124, 2002. View at Scopus
  29. R. Osborne and A. Gerulath, “What is the best regimen for low-risk gestational trophoblastic neoplasia? A review,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 8, pp. 602–616, 2004. View at Scopus
  30. E. S. Petrilli, L. B. Twiggs, J. A. Blessing, N. N. H. Teng, and S. Curry, “Single-dose Actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Ongology Group,” Cancer, vol. 60, no. 9, pp. 2173–2176, 1987. View at Scopus
  31. V. Fulop, I. Szigetvari, J. Szepesi, et al., “30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 55, pp. 253–257, 2006.
  32. J. P. Roberts and J. R. Lurain, “Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy,” American Journal of Obstetrics and Gynecology, vol. 174, no. 6, pp. 1917–1924, 1996. View at Publisher · View at Google Scholar
  33. P. G. Rose and M. S. Piver, “Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease,” Journal of Surgical Oncology, vol. 41, no. 3, pp. 148–152, 1989. View at Scopus
  34. W. B. Growdon, A. J. Wolfberg, D. P. Goldstein et al., “Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia,” Gynecologic Oncology, vol. 112, no. 2, pp. 353–357, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. R. J. Osborne, V. Filiaci, J. C. Schink et al., “Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study,” Journal of Clinical Oncology, vol. 29, no. 7, pp. 825–831, 2011. View at Publisher · View at Google Scholar · View at PubMed
  36. S. McGrath, D. Short, R. Harvey, P. Schmid, P. M. Savage, and M. J. Seckl, “The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1),” British Journal of Cancer, vol. 102, no. 5, pp. 810–814, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. G. J. S. Rustin, E. S. Newlands, J. M. Lutz et al., “Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors,” Journal of Clinical Oncology, vol. 14, no. 10, pp. 2769–2773, 1996. View at Scopus
  38. L. Rojas-Espaillat, K. L. Houck, E. Hernandez, and R. S. Berkowitz, “Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 52, no. 5, pp. 431–434, 2007. View at Scopus
  39. M. Allison, S. Case, T. J. Wilson, and E. M. Greenblatt, “Fertility-sparing surgery, with subsequent pregnancy, in persistent gestational trophoblastic neoplasia,” Human Reproduction, vol. 16, no. 2, pp. 360–364, 2001. View at Scopus
  40. N. Behtash, S. Ansari, and F. Sarvi, “Successful pregnancy after localized resection of perforated uterus in choriocarcinoma and a literature review,” International Journal of Gynecological Cancer, vol. 16, pp. 445–448, 2006. View at Publisher · View at Google Scholar · View at PubMed
  41. S. J. Kim, S. N. Bae, J. H. Kim, C. J. Kim, and J. K. Jung, “Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen,” Gynecologic Oncology, vol. 71, no. 2, pp. 247–253, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. S. L. Curry, J. A. Blessing, P. J. DiSaia, J. T. Soper, and L. B. Twiggs, “A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in ‘poor prognosis’ metastatic gestational trophoblastic disease: a gynecologic oncology group study,” Obstetrics and Gynecology, vol. 73, no. 3, pp. 357–362, 1989. View at Scopus
  43. B. DuBeshter, R. S. Berkowitz, and D. P. Goldstein, “Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985,” Obstetrics and Gynecology, vol. 69, no. 3, pp. 390–395, 1987. View at Scopus
  44. A. N. Gordon, D. M. Gershenson, L. J. Copeland, C. A. Stringer, M. Morris, and J. T. Wharton, “High-risk metastatic gestational trophoblastic disease: further stratification into two clinical entities,” Gynecologic Oncology, vol. 34, no. 1, pp. 54–56, 1989. View at Scopus
  45. M. Bower, E. S. Newlands, L. Holden et al., “EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients,” Journal of Clinical Oncology, vol. 15, no. 7, pp. 2636–2643, 1997. View at Scopus
  46. G. Bolis, C. Bonazzi, F. Landoni et al., “EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT),” Gynecologic Oncology, vol. 31, no. 3, pp. 439–444, 1988. View at Scopus
  47. S. J. Kim, S. N. Bae, J. H. Kim, C. T. Kim, K. T. Han, and J. M. Lee, “Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT—25 years experiences of KRI-TRD,” International Journal of Gynecology and Obstetrics, vol. 60, pp. S85–S96, 1998.
  48. K. D. Bagshawe, “Treatment of high-risk choriocarcinoma,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 29, no. 11, pp. 813–820, 1984. View at Scopus
  49. J. R. Lurain, D. K. Singh, and J. C. Schink, “Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 10, pp. 767–772, 2006. View at Scopus
  50. J. T. Soper, A. C. Evans, D. L. Clarke-Pearson, A. Berchuck, G. Rodriguez, and C. B. Hammond, “Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblatic disease,” Obstetrics and Gynecology, vol. 83, no. 1, pp. 113–117, 1994. View at Scopus
  51. Y. Xiang, Z. Sun, X. Wan, and X. Yang, “EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 6, pp. 443–446, 2004. View at Scopus
  52. P. H. Willemse, J. G. Aalders, J. Bouma, and D. T. Sleijfer, “Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin,” Obstetrics and Gynecology, vol. 71, no. 3, pp. 438–440, 1988. View at Scopus
  53. S. Piamsomboon, A. P. Kudelka, W. Termrungruanglert et al., “Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature,” European Journal of Gynaecological Oncology, vol. 18, no. 6, pp. 453–456, 1997. View at Scopus
  54. J. P. Lotz, T. Andre, R. Donsimoni et al., “High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults,” Cancer, vol. 75, no. 3, pp. 874–885, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. J. R. Lurain and B. Nejad, “Secondary chemotherapy for high-risk gestational trophoblastic neoplasia,” Gynecologic Oncology, vol. 97, no. 2, pp. 618–623, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. R. M. Clark, N. S. Nevadunsky, S. Ghosh, D. P. Goldstein, and R. S. Berkowitz, “The evolving role of hysterectomy in gestational Trophoblastic neoplasia at the new England trophoblastic disease center,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 55, no. 5-6, pp. 194–198, 2010.
  57. J. T. Soper, “Surgical therapy for gestational trophoblastic disease,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 39, no. 3, pp. 168–174, 1994. View at Scopus
  58. Y. Tomoda, Y. Arii, and S. Kaseki, “Surgical indications for resection in pulmonary metastasis of choriocarcinoma,” Cancer, vol. 46, no. 12, pp. 2723–2730, 1980. View at Scopus
  59. E. L. Fleming, L. Garrett, W. B. Growdon et al., “The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 53, no. 7, pp. 493–498, 2008. View at Scopus
  60. J. L. Edwards, A. R. Makey, and K. D. Bagshawe, “The role of thoractomy in the management of the pulmonary metastases of gestational choriocarcinoma,” Clinical Oncology, vol. 1, no. 4, pp. 329–339, 1975. View at Scopus
  61. R. L. Shirley, D. P. Goldstein, and J. J. Collins Jr., “The role of thoracotomy in the management of patients with chest metastases from gestational trophoblastic disease,” Journal of Thoracic and Cardiovascular Surgery, vol. 63, no. 4, pp. 545–550, 1972. View at Scopus
  62. Y. A. Wang, H. Z. Song, Z. F. Xia, et al., “Drug resistant pulmonary choriocarcinoma metastasis treated by lobectomy. Report of 29 cases,” Chinese Medical Journal, vol. 93, no. 11, pp. 758–766, 1980. View at Scopus
  63. J. D. Sink, C. B. Hammond, and W. G. Young, “Pulmonary resection in the management of metastases from gestational choriocarcinoma,” Journal of Thoracic and Cardiovascular Surgery, vol. 81, no. 6, pp. 830–834, 1981. View at Scopus
  64. E. Lehman, D. M. Gershenson, T. W. Burke, C. Levenback, E. G. Silva, and M. Morris, “Salvage surgery for chemorefractory gestational trophoblastic disease,” Journal of Clinical Oncology, vol. 12, no. 12, pp. 2737–2742, 1994. View at Scopus
  65. E. S. Newlands, L. Holden, M. J. Seckl, I. McNeish, S. Strickland, and G. J. S. Rustin, “Management of brain metastases in patients with high-risk gestational trophoblastic tumors,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 47, no. 6, pp. 465–471, 2002. View at Scopus
  66. E. S. Newlands, K. D. Bagshawe, R. H. J. Begent, G. J. S. Rustin, and L. Holden, “Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989,” British Journal of Obstetrics and Gynaecology, vol. 98, no. 6, pp. 550–557, 1991. View at Scopus
  67. E. L. Yordan Jr., J. Schlaerth, O. Gaddis, and C. P. Morrow, “Radiation therapy in the management of gestational choriocarcinoma metastatic to the central nervous system,” Obstetrics and Gynecology, vol. 69, no. 4, pp. 627–630, 1987. View at Scopus
  68. A. C. Evans Jr., J. T. Soper, D. L. Clarke-Pearson, A. Berchuck, G. C. Rodriguez, and C. B. Hammond, “Gestational trophoblastic disease metastatic to the central nervous system,” Gynecologic Oncology, vol. 59, no. 2, pp. 226–230, 1995. View at Publisher · View at Google Scholar
  69. L. C. Wong, Y. C. Choo, and H. K. Ma, “Hepatic metastases in gestational trophoblastic disease,” Obstetrics & Gynecology, vol. 67, no. 1, pp. 107–111, 1986.
  70. C. M. Feltmate, D. R. Genest, D. P. Goldstein, and R. S. Berkowitz, “Advances in the understanding of placental site trophoblastic tumor,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 47, no. 5, pp. 337–341, 2002.
  71. M. J. Seckl, N. J. Sebire, and R. S. Berkowitz, “Gestational trophoblastic disease,” Lancet, vol. 376, no. 9742, pp. 717–729, 2010.
  72. J. E. Palmer, M. Macdonald, M. Wells, B. W. Hancock, and J. A. Tidy, “Epithelioid trophoblastic tumor: a review of the literature,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 53, no. 7, pp. 465–475, 2008. View at Scopus
  73. M. S. F. S. Cagayan and M. S. Magallanes, “The role of adjuvant surgery in the management of gestational trophoblastic neoplasia,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 53, no. 7, pp. 513–518, 2008. View at Scopus
  74. K. Y. Tse, K. K. Chan, K. F. Tam, et al., “20-Year experience of managing profuse bleeding in gestational trophoblastic disease,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 52, no. 5, pp. 397–401, 2007. View at Scopus
  75. S. Yingna, X. Yang, Y. Xiuyu, and S. Hongzhao, “Clinical characteristics and treatment of gestational trophoblastic tumor with vaginal metastasis,” Gynecologic Oncology, vol. 84, no. 3, pp. 416–419, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. F. C. Grumbine, N. B. Rosenshein, H. D. Brereton, and S. L. Kaufman, “Management of liver metastasis from gestational trophoblastic neoplasia,” American Journal of Obstetrics and Gynecology, vol. 137, no. 8, pp. 959–961, 1980. View at Scopus
  77. L. A. Cole, “hCG, its free subunits and its metabolites: roles in pregnancy and trophoblastic disease,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 43, no. 1, pp. 3–10, 1998. View at Scopus
  78. L. A. Cole, E. I. Kohorn, and G. S. Kim, “Detecting and monitoring trophoblastic disease: new perspectives on measuring human chorionic gonadotropin levels,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 39, no. 3, pp. 193–200, 1994. View at Scopus
  79. L. A. Cole and S. Butler, “Detection of hCG in trophoblastic disease: the USA hCG reference service experience,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 47, no. 6, pp. 433–444, 2002. View at Scopus
  80. B. W. Hancock, “hCG measurement in gestational trophoblastic neoplasia: a critical appraisal,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 11, pp. 859–860, 2006. View at Scopus
  81. H. Mitchell, K. D. Bagshawe, E. S. Newlands, P. Savage, and M. J. Seckl, “Importance of accurate human chorionic gonadotropin measurement in the treatment of gestational trophoblast disease and testicular cancer,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 11, pp. 868–870, 2006. View at Scopus
  82. L. A. Cole and E. I. Kohorn, “The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 10, pp. 793–811, 2006. View at Scopus
  83. E. I. Kohorn, “What we know about low-level hCG: definition, classification and management,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 6, pp. 433–437, 2004. View at Scopus
  84. D. Hwang and B. W. Hancock, “Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 7, pp. 559–562, 2004. View at Scopus
  85. S. A. Khanlian and L. A. Cole, “Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 10, pp. 812–818, 2006. View at Scopus
  86. L. A. Cole, Y. Sasaki, and C. Y. Muller, “Normal production of human chorionic gonadotropin in menopause,” New England Journal of Medicine, vol. 356, no. 11, pp. 1184–1186, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. L. A. Cole, S. A. Khanlian, and C. Y. Muller, “Normal production of human chorionic gonadotropin in perimenopausal and menopausal women and after oophorectomy,” International Journal of Gynecological Cancer, vol. 19, no. 9, pp. 1556–1559, 2009. View at Scopus
  88. D. G. Mutch, J. T. Soper, C. J. Babcock, D. L. Clarke-Pearson, and C. B. Hammond, “Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center,” Cancer, vol. 66, no. 5, pp. 978–982, 1990. View at Scopus
  89. D. P. Goldstein, I. V. Zanten-Przybysz, M. R. Bernstein, and R. S. Berkowitz, “Revised FIGO staging system for gestational trophoblastic tumors: recommendations regarding therapy,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 43, no. 1, pp. 37–43, 1998. View at Scopus
  90. H. Y. S. Ngan, K. F. Tam, KA. W. Lam, and K. K. L. Chan, “Relapsed gestational trophoblastic neoplasia: a 20-year experience,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 51, no. 10, pp. 829–834, 2006. View at Scopus
  91. L. A. Garrett, E. I. O. Garner, C. M. Feltmate, D. P. Goldstein, and R. S. Berkowitz, “Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 53, no. 7, pp. 481–486, 2008. View at Scopus
  92. A. Ayhan, M. H. Ergeneli, K. Yuce, E. G. Yapar, and A. H. Kisnisci, “Pregnancy after chemotherapy for gestational trophoblastic disease,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 35, no. 5, pp. 522–524, 1990. View at Scopus
  93. J. H. Kim, D. C. Park, S. N. Bae, S. E. Namkoong, and S. J. Kim, “Subsequent reproductive experience after treatment for gestational trophoblastic disease,” Gynecologic Oncology, vol. 71, no. 1, pp. 108–112, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. J. J. Kjer and T. Iversen, “Malignant trophoblastic tumours in Norway. Fertility rate after chemotherapy,” British Journal of Obstetrics and Gynaecology, vol. 97, no. 7, pp. 623–625, 1990. View at Scopus
  95. O. Kobayashi, H. Matsui, and H. Takamizawa, “Analysis of pregnancy outcome after chemotherapy of trophoblastic disease,” Nippon Sanka Fujinka Gakkai Zasshi, vol. 38, no. 2, pp. 181–186, 1986.
  96. H. Y. S. Ngan, L. C. Wong, and H. K. Ma, “Reproductive performance of patients with gestational trophoblastic disease in Hong Kong,” Acta Obstetricia et Gynecologica Scandinavica, vol. 67, no. 1, pp. 11–14, 1988. View at Scopus
  97. H. Z. Song, P. C. Wu, Y. E. Wang, X. Y. Yang, and S. Y. Dong, “Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up,” American Journal of Obstetrics and Gynecology, vol. 158, no. 3 I, pp. 538–545, 1988. View at Scopus
  98. D. H. Van Thiel, G. T. Ross, and M. B. Lipsett, “Pregnancies after chemotherapy of trophoblastic neoplasms,” Science, vol. 169, no. 952, pp. 1326–1327, 1970. View at Scopus
  99. R. P. Woolas, M. Bower, E. S. Newlands, M. Seckl, D. Short, and L. Holden, “Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome,” British Journal of Obstetrics and Gynaecology, vol. 105, no. 9, pp. 1032–1035, 1998. View at Scopus
  100. H. Matsui, Y. Iitsuka, K. Suzuka, et al., “Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor,” The Journal of Reproductive Medicine, vol. 49, no. 7, pp. 531–534, 2004.
  101. R. Osborne, A. Covens, D. E. Merchandani, and A. Gerulath, “Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 8, pp. 655–661, 2004.
  102. J. Wang, D. Short, N. J. Sebire et al., “Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/ etoposide (TP/TE),” Annals of Oncology, vol. 19, no. 9, pp. 1578–1583, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. X. Wan, X. Yang, Y. Xiang et al., “Floxuridine-containing regimens in the treatment of gestational trophoblastic tumor,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 6, pp. 453–456, 2004. View at Scopus
  104. H. Matsui, Y. Iitsuka, K. Suzuka, K. Yamazawa, A. Mitsuhashi, and S. Sekiya, “Salvage chemotherapy for high-risk gestational trophopblastic tumor,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 6, pp. 438–442, 2004. View at Scopus
  105. A. N. Gordon, J. J. Kavanagh, and D. M. Gershenson, “Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease,” Cancer, vol. 58, no. 7, pp. 1407–1410, 1986. View at Scopus
  106. B. DuBeshter, R. S. Berkowitz, D. P. Goldstein, and M. Bernstein, “Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 34, no. 3, pp. 189–192, 1989. View at Scopus
  107. M. Azab, J. P. Droz, C. Theodore, J. P. Wolff, and J. L. Amiel, “Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors,” Cancer, vol. 64, no. 9, pp. 1829–1832, 1989. View at Scopus
  108. W. B. Jones, J. Schneider, F. Shapiro, and J. L. Lewis, “Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases,” Gynecologic Oncology, vol. 61, no. 1, pp. 126–130, 1996. View at Publisher · View at Google Scholar · View at Scopus
  109. G. P. Sutton, J. T. Soper, J. A. Blessing, K. D. Hatch, and D. R. Barnhill, “Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease,” American Journal of Obstetrics and Gynecology, vol. 167, no. 2, pp. 489–495, 1992. View at Scopus
  110. P. L. Giacalone, P. Benos, D. Donnadio, and F. Laffargue, “High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease,” Gynecologic Oncology, vol. 58, no. 3, pp. 383–385, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. K. Van Besien, C. Verschraegen, R. Mehra et al., “Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue,” Gynecologic Oncology, vol. 65, no. 2, pp. 366–369, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  112. M. S. F. S. Cagayan, “Sexual dysfunction as a complication of treatment of gestational trophoblastic neoplasia,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 53, no. 8, pp. 595–599, 2008.